Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EN6204 | — |
In late 2022, developed papillary renal cell carcinoma, resulting in partial nephrectomy 4/13/2023. Following that, development of cardiac issues tracked over following year, resulting in cardiac mri suggesting myocarditis. Myocarditis confirmed by 2nd cardiac mri 6/24/25
Hyper-tension
Lotrel 10/20, hydrochlorothiazide, testosterone cypionate .5 iu/week
N/A
Myocarditis: Numerous blood tests indicating high CK , high CK MB and troponin levels leading to multiple cardiac mri, first 3/11/2025. 2nd confirmatory cardiac mri 6/24/25. Relative to papillary renal cell carcinoma, multiple mris and ultimately partial nephrectomy 4/14/23